These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15841886)

  • 1. Evaluating the safety and tolerability profile of acute treatments for migraine.
    Martin VT; Goldstein JA
    Am J Med; 2005 Mar; 118 Suppl 1():36S-44S. PubMed ID: 15841886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiating and optimizing acute therapy for migraine: the role of patient-centered stratified care.
    Diamond M; Cady R
    Am J Med; 2005 Mar; 118 Suppl 1():18S-27S. PubMed ID: 15841884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical considerations for the treatment of elderly patients with migraine.
    Sarchielli P; Mancini ML; Calabresi P
    Drugs Aging; 2006; 23(6):461-89. PubMed ID: 16872231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute management of migraine.
    Chowdhury D
    J Assoc Physicians India; 2010 Apr; 58 Suppl():21-5. PubMed ID: 21049703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of triptans in the treatment of patients with migraine.
    Jamieson DG
    Am J Med; 2002 Feb; 112(2):135-40. PubMed ID: 11835952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug safety in acute migraine treatment.
    Tajti J; Majláth Z; Szok D; Csáti A; Vécsei L
    Expert Opin Drug Saf; 2015 Jun; 14(6):891-909. PubMed ID: 25773005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication overuse headache.
    Diener HC; Katsarava Z
    Curr Med Res Opin; 2001; 17 Suppl 1():s17-21. PubMed ID: 12463272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine treatment patterns and patient satisfaction with prior therapy: a substudy of a multicenter trial of rizatriptan effectiveness.
    Ceballos Hernansanz MA; Sanchez Roy R; Cano Orgaz A; López-Gil A;
    Clin Ther; 2003 Jul; 25(7):2053-69. PubMed ID: 12946550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of new acute treatments for migraine.
    Lupi C; Benemei S; Guerzoni S; Pellesi L; Negro A
    Expert Opin Drug Metab Toxicol; 2019 Mar; 15(3):189-198. PubMed ID: 30714429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin 1D (5-HT1D) agonists and other agents in acute migraine.
    Mathew NT
    Neurol Clin; 1997 Feb; 15(1):61-83. PubMed ID: 9058397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of adverse events in placebo groups of anti-migraine clinical trials.
    Amanzio M; Corazzini LL; Vase L; Benedetti F
    Pain; 2009 Dec; 146(3):261-269. PubMed ID: 19781854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.
    VanderPluym JH; Halker Singh RB; Urtecho M; Morrow AS; Nayfeh T; Torres Roldan VD; Farah MH; Hasan B; Saadi S; Shah S; Abd-Rabu R; Daraz L; Prokop LJ; Murad MH; Wang Z
    JAMA; 2021 Jun; 325(23):2357-2369. PubMed ID: 34128998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of migraines and migraine variants.
    Harmon TP
    Prim Care; 2015 Jun; 42(2):233-41. PubMed ID: 25979584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of migraine and action of antimigraine medications.
    Spierings EL
    Med Clin North Am; 2001 Jul; 85(4):943-58, vi-vii. PubMed ID: 11480266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptans in childhood and adolescence.
    Winner P
    Semin Pediatr Neurol; 2001 Mar; 8(1):22-6. PubMed ID: 11332862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability of the triptans: clinical implications.
    Nappi G; Sandrini G; Sances G
    Drug Saf; 2003; 26(2):93-107. PubMed ID: 12534326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of medications commonly used in the treatment of migraine.
    Whyte CA; Tepper SJ
    Expert Rev Neurother; 2009 Sep; 9(9):1379-91. PubMed ID: 19769452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.